Strides Pharma

Historical price data

Strides Pharma is a global pharmaceutical company headquartered in Bengaluru, India, with a core mission to provide affordable, high-quality generic medicines worldwide. The company has established itself as a leader in niche and complex therapeutic segments, including anti-retrovirals, anti-malarials, and softgel technologies, with a significant footprint in the US, Africa, Asia, and other regulated markets. Its strategic direction involves expanding its portfolio of complex generics, biosimilars, and specialty products while leveraging its robust manufacturing and R&D capabilities. Key achievements include a successful IPO, strategic acquisitions, and a consistent track record of ANDA filings and approvals in the US market.

Specialized expertise in complex generic formulation development and manufacturing, with leading capabilities in softgel capsule technology, sterile injectables, and the development of biosimilars.

1 drug in pipeline

Total raised: $50M

Strides competes with large Indian and global generic manufacturers, differentiating itself through specialized capabilities in softgels, injectables, and complex products, alongside a balanced presence in both regulated and emerging markets.